ClinConnect ClinConnect Logo
Search / Trial NCT02267837

OrthoPulse™ and Its Effect on the Rate of Orthodontic Tooth Alignment: A Pilot Feasibility Study

Launched by BIOLUX RESEARCH HOLDINGS, INC. · Oct 15, 2014

Trial Information

Current as of May 13, 2025

Completed

Keywords

Alignment Phase Photobiomodulation Orthodontic Treatment Malocclusion Ortho Pulse™

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Presence of permanent dentition
  • Eligible and scheduled for full mouth fixed orthodontic treatment
  • Class I or Class II malocclusion (no more than ½ cusp in Class II)
  • Non-extraction in all quadrants
  • Non-smoker
  • Good oral hygiene as determined by the investigator
  • No adjunct treatment such as extra- or intra-oral appliances
  • Exclusion Criteria:
  • Pregnant females
  • Patient is currently enrolled in another clinical study
  • Non-steroidal Anti-Inflammatory drug (NSAID) use during study (Acetominophen acceptable)
  • Periodontally involved teeth
  • Use of bisphosphonates
  • Unerupted or partially erupted maxillary teeth
  • Teeth blocked out of alignment and unable to engage initial arch wire
  • Spaces present in the maxillary arch

About Biolux Research Holdings, Inc.

Biolux Research Holdings, Inc. is a leading clinical research organization dedicated to advancing innovative therapies through rigorous scientific investigation and collaboration. With a focus on optimizing clinical trial design and execution, Biolux leverages its expertise in various therapeutic areas to support pharmaceutical and biotechnology companies in bringing new treatments to market. The organization is committed to upholding the highest standards of quality and compliance, ensuring that all research activities are conducted ethically and efficiently. Through its comprehensive approach, Biolux aims to accelerate the development of groundbreaking healthcare solutions that improve patient outcomes globally.

Locations

Suwanee, Georgia, United States

Patients applied

0 patients applied

Trial Officials

Timothy Shaughnessy, DDS

Principal Investigator

Shaughnessy Orthodontics

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials